|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Prevention, Treatment
|
|
|
|
Enrolling by invitation
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
C.2005.087 NCT00384124
|
|
|
|
|
|
|
|
Last Modified: 6/25/2007  First Published: 7/26/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Any age
|
|
|
|
Other
|
|
|
|
CRUK-LON-SINS-C7484/A2869 EU-20205, NCT00066872
|
|
|
|
|
|
|
|
Last Modified: 4/30/2004  First Published: 3/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NCCTG-989251 NCI-P02-0208, NCT00031759
|
|
|
|
|
|
|
|
Last Modified: 9/9/2005  First Published: 2/20/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
NCI-02-CC-0289 3M-1454-IMIQ, NCT00079300
|
|
|
|
|
|
|
|
Last Modified: 7/10/2006  First Published: 6/25/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
12 and over
|
|
|
|
NCI
|
|
|
|
UVACC-MEL-45 UVACC-HIC-11490, UVACC-34204, NCT00118313
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
NYU 04-53, LUD2004-006 NCT00142454
|
|
|
|
|
|
|
|
Last Modified: 12/3/2008  First Published: 3/22/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase I
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Closed
|
|
|
|
18 to 100
|
|
|
|
Other
|
|
|
|
OU-12576 12576, OU-ISPI, NCT00453050
|
|
|
|
|
|
|
|
Last Modified: 12/9/2008  First Published: 2/27/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
No phase specified
|
|
|
|
Diagnostic, Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
DUMC-PRO00000581 Pro00000581, SPORE Project 3, NCT00626483
|
|
|
|